Skip to main content

BBP · Virtus Biotech Etf

ETFis Series Trust I

SEC fund profile
$102.07 -1.82% At close · Oct 23
Net assets $98,543,965
Holdings70
1 month
-2.47%
Year to date
+27.72%
52-week range
$72.40–$110.05
30-session avg volume
15,326

Market performance

Adjusted close · up to five years

Since Oct 2021

Fund profile

Structure
Open-end / ETF
SEC series
S000047354
Report date
Jul 31, 2026
Holdings coverage
Full reported portfolio

Portfolio concentration

Top 10 holdings19.61%

Calculated only when the SEC filing is stored with complete portfolio coverage.

Asset allocation

EC99.80%
STIV0.71%

Country allocation

US84.60%
KY3.58%
GB3.58%
CH2.97%
BM1.55%
DK1.54%
DE1.38%
CA1.30%

Portfolio holdings

Latest linked SEC Form NPORT-P report.

Export CSV
HoldingValueWeight
CRINETICS PHARMACEUTICALS INC$3,288,4333.34%
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC$1,944,3631.97%
VERASTEM INC$1,919,8751.95%
PRECIGEN INC$1,912,2061.94%
OMEROS CORP$1,839,5691.87%
NUVATION BIO INC$1,746,0861.77%
REGENERON PHARMACEUTICALS$1,691,5131.72%
PROTAGONIST THERAPEUTICS INC$1,689,2801.71%
ACADIA PHARMACEUTICALS INC$1,664,7351.69%
BRIDGEBIO PHARMA INC$1,627,0281.65%
BEONE MEDICINES LTD$1,621,7631.65%
XERIS BIOPHARMA HOLDINGS INC$1,614,9901.64%
HALOZYME THERAPEUTICS INC$1,611,8411.64%
LIQUIDIA CORP$1,602,5481.63%
IMMUNOCORE HOLDINGS PLC$1,584,4381.61%
IRONWOOD PHARMACEUTICALS INC$1,572,8111.60%
ARROWHEAD PHARMACEUTICALS INC$1,541,6461.56%
ROIVANT SCIENCES LTD$1,532,0201.55%
LIGAND PHARMACEUTICALS$1,526,8371.55%
RHYTHM PHARMACEUTICALS INC$1,524,1821.55%
GERON CORP$1,522,3661.54%
RIGEL PHARMACEUTICALS INC$1,520,7321.54%
ASCENDIS PHARMA A/S$1,518,0961.54%
ARCUTIS BIOTHERAPEUTICS INC$1,495,1891.52%
INCYTE CORP$1,494,7171.52%
CYTOKINETICS INC$1,492,1571.51%
MODERNA INC$1,490,6111.51%
AMGEN INC$1,471,3111.49%
TRAVERE THERAPEUTICS INC$1,457,4991.48%
KRYSTAL BIOTECH INC$1,456,2411.48%
VERTEX PHARMACEUTICALS INC$1,456,1091.48%
BIOMARIN PHARMACEUTICAL INC$1,455,7851.48%
ZAI LAB LTD$1,452,5561.47%
MIRUM PHARMACEUTICALS INC$1,447,3831.47%
DENALI THERAPEUTICS INC$1,442,3871.46%
TG THERAPEUTICS INC$1,425,9861.45%
NEUROCRINE BIOSCIENCES INC$1,416,7991.44%
SYNDAX PHARMACEUTICALS INC$1,416,6341.44%
GILEAD SCIENCES INC$1,407,1791.43%
BIOCRYST PHARMACEUTICALS INC$1,400,8171.42%
ADMA BIOLOGICS INC$1,398,4801.42%
ULTRAGENYX PHARMACEUTICAL IN$1,388,3341.41%
HARMONY BIOSCIENCES HOLDINGS INC$1,387,8571.41%
AGIOS PHARMACEUTICALS INC$1,382,9311.40%
BIOGEN INC$1,377,0161.40%
THERAVANCE BIOPHARMA INC$1,375,1021.40%
IMMUNITYBIO INC$1,370,5311.39%
INSMED INC$1,367,5821.39%
BIONTECH SE$1,357,7041.38%
EXELIXIS INC$1,354,5981.37%

Showing the top 50 of 70 holdings. Create a free account to see every holding and download the CSV.